Experiment 626544

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOEFFECTS DUE TO A COMBINATION OF DRUGSPATENT DESCRIBED

Compounds isolated

TRIPTOLIDE

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.

Details

PropertyValue
Pharmacology
ALLOGRAFT REJECTION INHIBITION
Administration routeIP
OrganismTripterygium wilfordii (CELASTRACEAE)
CitationWIEDMANN,TWT: WANG,J:. (1998). METHOD FOR SUPPRESSING XENOGRAFT REJECTION.. ()
Amount utilized
Compound isolated
DiseaseIN PRESENCE OF 10.0 MG/KG CYCLOSPORIN A.
Dose amount0.25 MG
Number14
Qualitative resultACTIVE
AnimalRAT
Per unitKG
Dose expressionDOSE
GenderMALE